The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism (Q34448291)

2 August 2017

1 reference

title

The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism (English)

1 reference

2 August 2017

Teresa Zelante

2

0 references

Franco Aversa

object named as

Franco Aversa

7

0 references

Paolo Puccetti

object named as

Paolo Puccetti

8

0 references

Luigina Romani

object named as

Luigina Romani

1

0 references

author name string

Melissa Palmieri

3

1 reference

2 August 2017

Valerio Napolioni

4

1 reference

2 August 2017

Matteo Picciolini

5

1 reference

2 August 2017

Andrea Velardi

6

1 reference

2 August 2017

18 November 2014

1 reference

Seminars in Immunopathology

2 August 2017

1 reference

2 August 2017

37

1 reference

2 August 2017

163-171

1 reference

2 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00281-014-0464-2

2 August 2017

0 references

cites work

Host-gut microbiota metabolic interactions

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Interactions between the microbiota and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Review article: fungal microbiota and digestive diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Advances in combating fungal diseases: vaccines on the threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The mycobiota: interactions between commensal fungi and the host immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The human mycobiome in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

A tool kit for quantifying eukaryotic rRNA gene sequences from human microbiome samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Abundant and diverse fungal microbiota in the murine intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The role of the microbiome in exacerbations of chronic lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Characterization of the oral fungal microbiome (mycobiome) in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Fungi and inflammatory bowel diseases: Alterations of composition and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Autophagy is redundant for the host defense against systemic Candida albicans infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Medically important bacterial-fungal interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Role of Candida in antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Modulation of post-antibiotic bacterial community reassembly and host response by Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Foxp3(+) T cells regulate immunoglobulin a selection and facilitate diversification of bacterial species responsible for immune homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Does the microbiota regulate immune responses outside the gut?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Sensing of mammalian IL-17A regulates fungal adaptation and virulence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Candida albicans colonization and ASCA in familial Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Role of antibiotics and fungal microbiota in driving pulmonary allergic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Skin diseases associated with Malassezia yeasts: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The cross talk between microbiota and the immune system: metabolites take center stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The human indoleamine 2,3-dioxygenase gene and related human genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Indoleamine 2,3-dioxygenase: from catalyst to signaling function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Indoleamine 2,3 dioxygenase and metabolic control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Indoleamine 2,3-dioxygenases with very low catalytic activity are well conserved across kingdoms: IDOs of Basidiomycota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The aryl hydrocarbon receptor: multitasking in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Functions of the aryl hydrocarbon receptor in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

AhR ligands, malassezin, and indolo[3,2-b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The search for endogenous activators of the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

IL-22 in antifungal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Finding the missing links among metabolites, microbes, and the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Activation of the Ah receptor by tryptophan and tryptophan metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The role of microbiota and probiotics in stress-induced gastro-intestinal damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The microbiome of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

The microbiome and the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Pulmonary aspergillosis: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Immunity to fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0464-2

Yeasts in the gut: from commensals to infectious agents

21 January 2018

1 reference

12 December 2020

The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells

1 reference

12 December 2020

An immunological link between Candida albicans colonization and Crohn's disease.

1 reference

12 December 2020

Malassezia-derived indoles activate the aryl hydrocarbon receptor and inhibit Toll-like receptor-induced maturation in monocyte-derived dendritic cells

1 reference

12 December 2020

Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients.

1 reference

12 December 2020

AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch

1 reference

12 December 2020

Influences of Dietary and Environmental Stress on Microbial Populations in the Murine Gastrointestinal Tract

1 reference

12 December 2020

Chronic mucocutaneous candidiasis, from bench to bedside

1 reference

12 December 2020

Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease

1 reference

12 December 2020

AhR: far more than an environmental sensor

1 reference

12 December 2020

Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans.

1 reference

12 December 2020

10.1007/S00281-014-0464-2

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference